Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Year-over-year earnings per share growth rate
3Y CAGR
-69.2%/yr
Annual compound
Percentile
P50
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 0.46% |
| 2024 | -342.22% |
| 2023 | 192.78% |
| 2022 | 15.65% |
| 2021 | 0.00% |